Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study.
Michalet M, Bordeau K, Cantaloube M, Valdenaire S, Debuire P, Simeon S, Portales F, Draghici R, Ychou M, Assenat E, Dupuy M, Gourgou S, Colombo PE, Carrere S, Souche FR, Aillères N, Fenoglietto P, Azria D, Riou O.
Michalet M, et al. Among authors: ailleres n.
Front Oncol. 2022 Mar 9;12:842402. doi: 10.3389/fonc.2022.842402. eCollection 2022.
Front Oncol. 2022.
PMID: 35356227
Free PMC article.